Ph n cho con b
82 VazF
outlined several systemic advantages of GLP-1 RAs, including weight loss, glycemic control, cardiovascular protection (e.g., reduced incidence of myocardial infarction and stroke), and their role as a non-surgical alternative to bariatric procedures
A research article published by JAMA in 2022 states that 48.6% of the participants had gastrointestinal side effects
Beyond physical effects, the financial and emotional burden of continuous medicationanxiety about missed doses, frustration over plateauing results, and the high cost of ongoing treatmentcan take a toll
But 'very weak' isn't 'zero.' At very high, supra-physiological doses not typically used in responsible research, some minor, transient elevations might be observed